Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1978 1
1979 8
1980 4
1981 3
1982 2
1984 1
1985 1
1986 3
1987 2
1988 2
1989 3
1990 2
1991 1
1992 1
1994 2
1995 1
1996 2
1998 1
1999 2
2002 1
2003 1
2004 1
2005 1
2006 3
2007 4
2008 1
2009 3
2010 1
2011 1
2012 2
2013 5
2014 7
2015 8
2016 14
2017 15
2018 19
2019 20
2020 34
2021 34
2022 21
2023 26
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
de Baat EC, van Dalen EC, Mulder RL, Hudson MM, Ehrhardt MJ, Engels FK, Feijen EAM, Grotenhuis HB, Leerink JM, Kapusta L, Kaspers GJL, Merkx R, Mertens L, Skinner R, Tissing WJE, de Vathaire F, Nathan PC, Kremer LCM, Mavinkurve-Groothuis AMC, Armenian S. de Baat EC, et al. Among authors: ehrhardt mj. Lancet Child Adolesc Health. 2022 Dec;6(12):885-894. doi: 10.1016/S2352-4642(22)00239-5. Epub 2022 Sep 27. Lancet Child Adolesc Health. 2022. PMID: 36174614 Review.
Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Ehrhardt MJ, Leerink JM, Mulder RL, Mavinkurve-Groothuis A, Kok W, Nohria A, Nathan PC, Merkx R, de Baat E, Asogwa OA, Skinner R, Wallace H, Lieke Feijen EAM, de Ville de Goyet M, Prasad M, Bárdi E, Pavasovic V, van der Pal H, Fresneau B, Demoor-Goldschmidt C, Hennewig U, Steinberger J, Plummer C, Chen MH, Teske AJ, Haddy N, van Dalen EC, Constine LS, Chow EJ, Levitt G, Hudson MM, Kremer LCM, Armenian SH. Ehrhardt MJ, et al. Lancet Oncol. 2023 Mar;24(3):e108-e120. doi: 10.1016/S1470-2045(23)00012-8. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052966 Review.
Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort.
Dixon SB, Liu Q, Chow EJ, Oeffinger KC, Nathan PC, Howell RM, Leisenring WM, Ehrhardt MJ, Ness KK, Krull KR, Mertens AC, Hudson MM, Robison LL, Yasui Y, Armstrong GT. Dixon SB, et al. Among authors: ehrhardt mj. Lancet. 2023 Apr 29;401(10386):1447-1457. doi: 10.1016/S0140-6736(22)02471-0. Epub 2023 Apr 5. Lancet. 2023. PMID: 37030315
Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer.
Wang Y, Ronckers CM, van Leeuwen FE, Moskowitz CS, Leisenring W, Armstrong GT, de Vathaire F, Hudson MM, Kuehni CE, Arnold MA, Demoor-Goldschmidt C, Green DM, Henderson TO, Howell RM, Ehrhardt MJ, Neglia JP, Oeffinger KC, van der Pal HJH, Robison LL, Schaapveld M, Turcotte LM, Waespe N, Kremer LCM, Teepen JC; International Consortium for Pooled Studies on Subsequent Malignancies after Childhood and Adolescent Cancer. Wang Y, et al. Among authors: ehrhardt mj. Nat Med. 2023 Sep;29(9):2268-2277. doi: 10.1038/s41591-023-02514-1. Epub 2023 Sep 11. Nat Med. 2023. PMID: 37696934 Free PMC article.
Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.
Chow EJ, Leger KJ, Bhatt NS, Mulrooney DA, Ross CJ, Aggarwal S, Bansal N, Ehrhardt MJ, Armenian SH, Scott JM, Hong B. Chow EJ, et al. Among authors: ehrhardt mj. Cardiovasc Res. 2019 Apr 15;115(5):922-934. doi: 10.1093/cvr/cvz031. Cardiovasc Res. 2019. PMID: 30768157 Free PMC article. Review.
Renal and Hepatic Health After Childhood Cancer.
Ehrhardt MJ, Skinner R, Castellino SM. Ehrhardt MJ, et al. Pediatr Clin North Am. 2020 Dec;67(6):1203-1217. doi: 10.1016/j.pcl.2020.07.011. Epub 2020 Sep 23. Pediatr Clin North Am. 2020. PMID: 33131542 Review.
Nonlinearity-induced photonic topological insulator.
Maczewsky LJ, Heinrich M, Kremer M, Ivanov SK, Ehrhardt M, Martinez F, Kartashov YV, Konotop VV, Torner L, Bauer D, Szameit A. Maczewsky LJ, et al. Among authors: ehrhardt m. Science. 2020 Nov 6;370(6517):701-704. doi: 10.1126/science.abd2033. Science. 2020. PMID: 33154138
A joint international consensus statement for measuring quality of survival for patients with childhood cancer.
van Kalsbeek RJ, Hudson MM, Mulder RL, Ehrhardt M, Green DM, Mulrooney DA, Hakkert J, den Hartogh J, Nijenhuis A, van Santen HM, Schouten-van Meeteren AYN, van Tinteren H, Verbruggen LC, Conklin HM, Jacola LM, Webster RT, Partanen M, Kollen WJW, Grootenhuis MA, Pieters R, Kremer LCM; International Childhood Cancer Outcome Project participants. van Kalsbeek RJ, et al. Among authors: ehrhardt m. Nat Med. 2023 Jun;29(6):1340-1348. doi: 10.1038/s41591-023-02339-y. Epub 2023 Jun 15. Nat Med. 2023. PMID: 37322119 Review.
241 results